Cigna Group announced Monday it is not pursuing a merger with Humana. The announcement squashes speculation fueled by Donald ...

"The Cigna Group remains committed to its established M&A criteria and would only consider acquisitions that are ...

Analyst Steve Baxter of Wells Fargo maintained a Hold rating on Cigna (CI – Research Report), retaining the price target of $355.00.

Additionally, in light of recent and persistent speculation, The Cigna Group expects to communicate that the company is not ...

The cryptocurrency market saw huge moves over the weekend following the Fed's decision last week to cut interest rates by ...

Last December, the two companies failed to agree on a price as Cigna pursued the purchase of the Louisville-based company.

LOUISVILLE, Ky. — The Cigna group announced on Monday they would no longer be pursuing a merger with their Louisville-based ...

The Cigna Group (NYSE: CI) said on Monday that it is officially not pursuing a combination with Humana Inc. (NYSE: HUM). That means that CenterWell Home ...

Shares of Cigna Group (NYSE: CI), the healthcare company, were rising today after the company announced in a press release ...

Cigna Group said Monday it is not pursuing a combination with rival Humana, days after Donald Trump's reelection as U.S. president raised investor hopes that any merger would face far less antitrust ...

Company officials said Monday they are not pursuing a merger with rival Humana, causing Cigna's stock to rise in the markets.

(Reuters) -Cigna projected 2025 profit growth of at least 10% on Thursday, after posting quarterly results that beat Wall Street expectations, driven by strong demand for its specialty drugs and ...